Scott Bratman is the founder of Adela. Adela has raised $108M in total funding. Latest round: Series A. Based in Toronto, Canada.
Scott Bratman is the President and a Board Member at Adela, a company focused on blood testing for minimal residual disease monitoring and early cancer detection using a genome-wide methylome approach. Adela has raised a total of $108 million in financing. Previously, Dr. Bratman served as CEO of Adela.
Full founder directory · Investor directory · Company funding database · Fundraising library